DR. MILTON DAVID GROSS, MD
Medical Practice in Ann Arbor, MI
License number
Michigan 4301035371
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301035371
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
License number
Michigan 4301035371
Category
Medical Practice
Type
Nuclear Medicine
Address
Address
1500 Floor University Hospital ROOM B1G412, Ann Arbor, MI 48109
Phone
(734) 936-5090
(734) 936-2047
(734) 936-2047
Personal information
See more information about MILTON DAVID GROSS at radaris.comName
Address
Phone
4153 High Rdg, Ann Arbor, MI 48105
883 Ridgeside Dr, Milford, MI 48381
3695 Middleton Dr, Ann Arbor, MI 48105
234 Teggeroine, Milford, MI 48380
234 Teromi Trl, Milford, MI 48381
Professional information
See more information about MILTON DAVID GROSS at trustoria.com
Milton Gross, Ann Arbor MI
Milton Gross, Ann Arbor MI
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Nuclear Medicine, Radiology, Body Imaging, Nuclear Radiology
Work:
Ann Arbor Veterans Affairs Medical Center
2215 Fuller Rd, Ann Arbor, MI 48105 Battle Creek Va Medical Center
5500 Armstrong Rd, Battle Creek, MI 49037 Aleda E Lutz Va Medical Center
1500 Weiss St, Saginaw, MI 48602 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
2215 Fuller Rd, Ann Arbor, MI 48105 Battle Creek Va Medical Center
5500 Armstrong Rd, Battle Creek, MI 49037 Aleda E Lutz Va Medical Center
1500 Weiss St, Saginaw, MI 48602 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Michigan Medical School (1974)
Milton David Gross, Ann Arbor MI
Milton David Gross, Ann Arbor MI
Specialties:
Nuclear Medicine Specialist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Michigan, Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Nuclear Medicine Certification in Nuclear Medicine
Dr. Milton D Gross, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Milton D Gross, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Nuclear Medicine
Address:
Univ Of MI Dept Of Nuclear Medi
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-5387 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-5387 (Phone)
Certifications:
Internal Medicine, 1977, Nuclear Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univ Of MI Dept Of Nuclear Medi
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Suny Downstate Medical Center
Graduated: 1955
University of Mi Med Sch
Graduated: 1974
University Of Michigan Hospitals
Suny Downstate Medical Center
Graduated: 1955
University of Mi Med Sch
Graduated: 1974
University Of Michigan Hospitals
Monoclonal Antibody Imaging And Therapy Of Tumors That Express Met And Bind Hepatocyte Growth Factor
Monoclonal Antibody Imaging And Therapy Of Tumors That Express Met And Bind Hepatocyte Growth Factor
US Patent:
2005011, Jun 2, 2005
Filed:
Dec 27, 2002
Appl. No.:
10/500297
Inventors:
Rick Hay - Ada MI, US
Boliang Cao - Ada MI, US
James Resau - Grand Rapids MI, US
George Vande Woude - Ada MI, US
Milton Gross - Ann Arbor MI, US
Boliang Cao - Ada MI, US
James Resau - Grand Rapids MI, US
George Vande Woude - Ada MI, US
Milton Gross - Ann Arbor MI, US
Assignee:
Van Andel Institute; and the USA as Represented by the Department Of Veterans Affairs - Grand Rapids MI
International Classification:
A61K039/395, C07K016/44
US Classification:
424141100, 530388150
Abstract:
In a wide variety of human solid tumors, an aggressive, metastatic phenotype and poor clinical prognosis are associated with expression of the receptor tyrosine kinase. Met and its agonist ligand HGF. Disclosed herein are (a) mAbs and hybridoma cell lines that produce them, which mAbs antibodies are specific for Met and (b) combinations of anti-Met and anti-HGF mAbs. When detectably labeled, these antibodies are useful for imaging such tumors. Anti-Met mAb compositions and methods for scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors are provided.